$INSM
INSMED Inc Stock $insm

$insm Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000110450620000011 Filed on April 30, 2020

Income Statement

Concept	2020 Q1	2019 Q1
Revenue	$36.86M	$21.90M
YoY Change	68.3%
Cost Of Revenue	$8.438M	$4.150M
YoY Change	103.33%
Gross Profit	$28.42M	$17.75M
YoY Change	60.11%
Gross Profit Margin	77.11%	81.05%
Selling, General & Admin	$51.35M	$54.81M
YoY Change	-6.31%	67.87%
% of Gross Profit	180.67%	308.75%
Research & Development	$36.18M	$31.20M
YoY Change	15.96%	3.67%
% of Gross Profit	127.31%	175.77%
Depreciation & Amortization	$2.266M	$1.069M
YoY Change	111.97%	39.01%
% of Gross Profit	7.97%	6.02%
Operating Expenses	$36.18M	$31.20M
YoY Change	15.96%	-50.27%
Operating Profit	-$60.36M	-$69.51M
YoY Change	-13.17%	10.77%
Interest Expense	$7.411M	$6.726M
YoY Change	10.18%	19.21%
% of Operating Profit
Other Income/Expense, Net	$36.00K	-$119.0K
YoY Change	-130.25%	-238.37%
Pretax Income	-$66.33M	-$73.94M
YoY Change	-10.29%	7.98%
Income Tax	$0.00	$200.0K
% Of Pretax Income
Net Earnings	-$66.36M	-$74.15M
YoY Change	-10.5%	8.21%
Net Earnings / Revenue	-180.04%	-338.57%
Basic Earnings Per Share
Diluted Earnings Per Share	-$739.1K	-$956.3K
COMMON SHARES
Basic Shares Outstanding	89.78M shares	77.54M shares
Diluted Shares Outstanding	89.78M shares	77.54M shares

Balance Sheet

Concept	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$428.9M	$420.2M
YoY Change	2.07%	-38.8%
Cash & Equivalents	$428.9M	$420.2M
Short-Term Investments
Other Short-Term Assets	$15.80M	$12.40M
YoY Change	27.42%	26.53%
Inventory	$30.65M	$12.68M
Prepaid Expenses
Receivables	$17.15M	$9.347M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$492.5M	$454.6M
YoY Change	8.33%	-34.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$58.64M	$27.93M
YoY Change	109.92%	76.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$21.90M	$11.30M
YoY Change	93.81%	318.52%
Total Long-Term Assets	$184.0M	$141.3M
YoY Change	30.25%	84.11%
TOTAL ASSETS
Total Short-Term Assets	$492.5M	$454.6M
Total Long-Term Assets	$184.0M	$141.3M
Total Assets	$676.5M	$595.9M
YoY Change	13.53%	-22.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.19M	$30.22M
YoY Change	-39.82%	129.38%
Accrued Expenses	$32.69M	$38.32M
YoY Change	-14.69%	81.82%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.300M
YoY Change
Total Short-Term Liabilities	$71.53M	$94.25M
YoY Change	-24.11%	170.79%
LONG-TERM LIABILITIES
Long-Term Debt	$340.9M	$321.3M
YoY Change	6.11%	6.15%
Other Long-Term Liabilities	$10.96M	$504.0K
YoY Change	2074.6%	-35.8%
Total Long-Term Liabilities	$351.9M	$321.8M
YoY Change	9.35%	6.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$71.53M	$94.25M
Total Long-Term Liabilities	$351.9M	$321.8M
Total Liabilities	$469.8M	$451.8M
YoY Change	3.99%	33.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.603B	-$1.356B
YoY Change	18.18%	32.14%
Common Stock	$899.0K	$776.0K
YoY Change	15.85%	1.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$206.7M	$144.1M
YoY Change
Total Liabilities & Shareholders Equity	$676.5M	$595.9M
YoY Change	13.53%	-22.92%

Cashflow Statement

Concept	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	-$66.36M	-$74.15M
YoY Change	-10.5%	8.21%
Depreciation, Depletion And Amortization	$2.266M	$1.069M
YoY Change	111.97%	39.01%
Cash From Operating Activities	-$57.94M	-$73.85M
YoY Change	-21.55%	9.54%
INVESTING ACTIVITIES
Capital Expenditures	$2.679M	$4.028M
YoY Change	-33.49%	-24.92%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$2.679M	-$4.028M
YoY Change	-33.49%	-24.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$2.134M	$3.049M
YoY Change	-30.01%	-99.19%
NET CHANGE
Cash From Operating Activities	-$57.94M	-$73.85M
Cash From Investing Activities	-$2.679M	-$4.028M
Cash From Financing Activities	$2.134M	$3.049M
Net Change In Cash	-$58.49M	-$74.84M
YoY Change	-21.85%	-124.5%
FREE CASH FLOW
Cash From Operating Activities	-$57.94M	-$73.85M
Capital Expenditures	$2.679M	$4.028M
Free Cash Flow	-$60.61M	-$77.88M
YoY Change	-22.17%	7.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27197000	USD
CY2020Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	VA
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001104506
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2020Q1	dei	Entity File Number EntityFileNumber	000-30739
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	INSMED INC
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	89878296	shares
CY2020Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	54-1972729
CY2020Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	700 US Highway 202/206
CY2020Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Bridgewater
CY2020Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2020Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08807
CY2020Q1	dei	City Area Code CityAreaCode	908
CY2020Q1	dei	Local Phone Number LocalPhoneNumber	977-9900
CY2020Q1	dei	Security12b Title Security12bTitle	Common stock, par value $0.01 per share
CY2020Q1	dei	Trading Symbol TradingSymbol	INSM
CY2020Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	428942000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	487429000	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17154000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19232000	USD
CY2020Q1	us-gaap	Inventory Net InventoryNet	30645000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	28313000	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15769000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	20220000	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	492510000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	555194000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	52433000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	53682000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	58638000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	60180000	USD
CY2020Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	14896000	USD
CY2019Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	15256000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	36137000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	37673000	USD
CY2020Q1	us-gaap	Other Assets OtherAssets	21911000	USD
CY2019Q4	us-gaap	Other Assets OtherAssets	20314000	USD
CY2020Q1	us-gaap	Assets Assets	676525000	USD
CY2019Q4	us-gaap	Assets Assets	742299000	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	18188000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	13184000	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	32687000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	40375000	USD
CY2020Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8949000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	19140000	USD
CY2020Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1263000	USD
CY2019Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1221000	USD
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10367000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11040000	USD
CY2020Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	78000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	280000	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	71532000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	85240000	USD
CY2020Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	340939000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	335940000	USD
CY2020Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	19196000	USD
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	19529000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	29308000	USD
CY2020Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10960000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10608000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	469824000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	480625000	USD
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	89859549	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	89859549	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	89682387	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	89682387	shares
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	899000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	897000	USD
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1808712000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1797286000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1602863000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1536499000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-47000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	206701000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	261674000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	676525000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	742299000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36860000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21902000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8438000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4150000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	28422000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	17752000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36184000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31203000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	51346000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	54810000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1249000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1248000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	88779000	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	87261000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-60357000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-69509000	USD
CY2020Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1404000	USD
CY2019Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	2416000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	7411000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	6726000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	36000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-119000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2679000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4028000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-66328000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-73938000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	215000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-66364000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-74153000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.74
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.96
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	89779000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	77541000	shares
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-66364000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-74153000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-37000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	39000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-66401000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-74114000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	208266000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-74153000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	39000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3049000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6936000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	144137000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	261674000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-66364000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-37000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2426000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9002000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	206701000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-66364000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-74153000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	2266000	USD
CY2019Q1	us-gaap	Depreciation Depreciation	1069000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1249000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1248000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	9002000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6936000	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	349000	USD
CY2019Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	349000	USD
CY2020Q1	insm	Amortization Of Debt Discount Premium And Accretion Expense AmortizationOfDebtDiscountPremiumAndAccretionExpense	4650000	USD
CY2019Q1	insm	Amortization Of Debt Discount Premium And Accretion Expense AmortizationOfDebtDiscountPremiumAndAccretionExpense	4406000	USD
CY2020Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	360000	USD
CY2019Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	USD
CY2020Q1	insm	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	1536000	USD
CY2019Q1	insm	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	2276000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2078000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3832000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5000000.0	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2332000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5650000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4341000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1061000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1568000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	7044000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4169000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9499000	USD
CY2020Q1	insm	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-7480000	USD
CY2019Q1	insm	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-1953000	USD
CY2020Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-10191000	USD
CY2019Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-5937000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-57935000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-73847000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2679000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4028000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	5000000.0	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	5000000.0	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2426000	USD
CY2019Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3049000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	428900000	USD
CY2020Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	292000	USD
CY2019Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2134000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3049000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-7000	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-15000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-58487000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-74841000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	487429000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	495072000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	428942000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	420231000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	4381000	USD
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	3939000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	414000	USD
CY2019Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	178000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-66400000	USD
CY2020Q1	insm	Fair Value Level1 Level2 Level3 Transfers Amount FairValueLevel1Level2Level3TransfersAmount	0	USD
CY2019Q1	insm	Fair Value Level1 Level2 Level3 Transfers Amount FairValueLevel1Level2Level3TransfersAmount	0	USD
CY2020Q1	insm	Availableforsale Securities Gross Unrealized Gain Loss Numberof Securities AvailableforsaleSecuritiesGrossUnrealizedGainLossNumberofSecurities	0	security
CY2019Q4	insm	Availableforsale Securities Gross Unrealized Gain Loss Numberof Securities AvailableforsaleSecuritiesGrossUnrealizedGainLossNumberofSecurities	0	security
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-66364000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-74153000	USD
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89779000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77541000	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89779000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77541000	shares
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.74
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.96
CY2020Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-indent:36pt;margin-top:8pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Concentration of Credit Risk</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">—Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company places its cash equivalents with high credit-quality financial institutions and may invest its short-term investments in US treasury securities, mutual funds and government agency bonds. The Company has established guidelines relative to credit ratings and maturities that seek to maintain safety and liquidity.</span></div><div style="text-indent:36pt;margin-top:8pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company is exposed to risks associated with extending credit to customers related to the sale of products. The Company does not require collateral to secure amounts due from its customers. The Company uses an expected loss methodology to calculate allowances for trade receivables. The Company's measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The Company does not currently have a material allowance for collectible trade receivables. The following table presents the percentage of gross product revenue represented by the </span></div><div style="margin-top:8pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Company's three largest customers as of the three months ended March 31, 2020 and March 31, 2019.</span></div><div style="text-align:center;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:67.836%;"><tr><td style="width:1.0%;"/><td style="width:37.008%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:27.094%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:2.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:27.097%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percentage of Total Gross Product Revenue</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" rowspan="2" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer A</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer B</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer C</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="text-indent:42.75pt;"><span><br/></span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company relies on third-party manufacturers and suppliers for manufacturing and supply of its products. The inability of the suppliers or manufacturers to fulfill supply requirements of the Company could materially impact future operating results. A change in the relationship with the suppliers or manufacturer, or an adverse change in their business, could materially impact future operating results.</span></div>
CY2020Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16992000	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16048000	USD
CY2020Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6761000	USD
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6420000	USD
CY2020Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6892000	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	5845000	USD
CY2020Q1	us-gaap	Inventory Net InventoryNet	30645000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	28313000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	52400000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	53700000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P12Y
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	5000000.0	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5000000.0	USD
CY2020Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	439000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	53682000	USD
CY2020Q1	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	0	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1249000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	52433000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	80116000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	79447000	USD
CY2020Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21478000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19267000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	58638000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	60180000	USD
CY2019Q4	us-gaap	Interest Payable Current InterestPayableCurrent	3631000	USD
CY2020Q1	insm	Accrued Sales Allowancesand Related Costs AccruedSalesAllowancesandRelatedCosts	7235000	USD
CY2019Q4	insm	Accrued Sales Allowancesand Related Costs AccruedSalesAllowancesandRelatedCosts	5267000	USD
CY2020Q1	insm	Accrued Clinical Trial Expenses AccruedClinicalTrialExpenses	4521000	USD
CY2019Q4	insm	Accrued Clinical Trial Expenses AccruedClinicalTrialExpenses	5598000	USD
CY2020Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	13233000	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	12581000	USD
CY2020Q1	insm	Accrued Technical Operation Expenses AccruedTechnicalOperationExpenses	1836000	USD
CY2019Q4	insm	Accrued Technical Operation Expenses AccruedTechnicalOperationExpenses	6446000	USD
CY2020Q1	insm	Accrued Royalties And Milestone Payments Current AccruedRoyaltiesAndMilestonePaymentsCurrent	2732000	USD
CY2019Q4	insm	Accrued Royalties And Milestone Payments Current AccruedRoyaltiesAndMilestonePaymentsCurrent	3117000	USD
CY2020Q1	us-gaap	Interest Payable Current InterestPayableCurrent	1663000	USD
CY2020Q1	insm	Accrued Construction Liabilities Current AccruedConstructionLiabilitiesCurrent	815000	USD
CY2019Q4	insm	Accrued Construction Liabilities Current AccruedConstructionLiabilitiesCurrent	2689000	USD
CY2020Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	652000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1046000	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	32687000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	40375000	USD
CY2020Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	360000	USD
CY2020Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	439000	USD
CY2020Q1	insm	Finance Lease Cost FinanceLeaseCost	799000	USD
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	2807000	USD
CY2020Q1	us-gaap	Lease Cost LeaseCost	3606000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	2838000	USD
CY2020Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	292000	USD
CY2020Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P10Y3M18D
CY2020Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y10M24D
CY2020Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.086
CY2020Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.074
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	22000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	47396000	USD
CY2020Q1	insm	Lessee Operating Lease Lease Notyet Commenced Amount LesseeOperatingLeaseLeaseNotyetCommencedAmount	20400000	USD
CY2020Q1	us-gaap	Secured Debt SecuredDebt	450000000	USD
CY2019Q4	us-gaap	Secured Debt SecuredDebt	450000000	USD
CY2020Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	6694000	USD
CY2019Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	7043000	USD
CY2020Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	102367000	USD
CY2019Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	107017000	USD
CY2020Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	340939000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	335940000	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	450000000	USD
CY2020Q1	us-gaap	Long Term Debt LongTermDebt	450000000	USD
CY2020Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1973000	USD
CY2019Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1971000	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	349000	USD
CY2019Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	349000	USD
CY2020Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4650000	USD
CY2019Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4406000	USD
CY2020Q1	insm	Convertible Debt Interest Expense Total ConvertibleDebtInterestExpenseTotal	6972000	USD
CY2019Q1	insm	Convertible Debt Interest Expense Total ConvertibleDebtInterestExpenseTotal	6726000	USD
CY2020Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	439000	USD
CY2019Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	7411000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	6726000	USD
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	89859549	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	89859549	shares
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2020Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q1	insm	Share Based Compensation Arrangement By Share Based Payment Award Inducement Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardInducementOptionsGrantsInPeriodGross	329260	shares
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0.0	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2019Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2020Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	800000	USD
CY2019Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	800000	USD

Files In Submission

Name	View Source	Status
0001104506-20-000011-index-headers.html	Edgar Link	pending
0001104506-20-000011-index.html	Edgar Link	pending
0001104506-20-000011.txt	Edgar Link	pending
0001104506-20-000011-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
insm-20200331.htm	Edgar Link	pending
insm-20200331.xsd	Edgar Link	pending
insm-20200331_cal.xml	Edgar Link	unprocessable
insm-20200331_def.xml	Edgar Link	unprocessable
insm-20200331_htm.xml	Edgar Link	completed
insm-20200331_lab.xml	Edgar Link	unprocessable
insm-20200331_pre.xml	Edgar Link	unprocessable
insm20200331ex101.htm	Edgar Link	pending
insm20200331ex311.htm	Edgar Link	pending
insm20200331ex312.htm	Edgar Link	pending
insm20200331ex321.htm	Edgar Link	pending
insm20200331ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INSM
INSMED Inc Stock $insm

2020 Q1 Form 10-Q Financial Statement

#000110450620000011 Filed on April 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INSM INSMED Inc Stock $insm

2020 Q1 Form 10-Q Financial Statement

#000110450620000011 Filed on April 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INSM
INSMED Inc Stock $insm